What is Physera?
Physera operates within the digital health sector, focusing on providing virtual care programs designed to address chronic conditions, particularly musculoskeletal (MSK) issues. The company's approach involves personalized treatment plans and integrated care pathways aimed at delivering lasting health improvements and cost savings for partners such as employers and health plans. Their MSK program has demonstrated notable success, with a high percentage of members showing improvement and significant cost reductions within the first year. Leveraging a national network of licensed physical therapists and advanced technology, Physera strives to ensure high member satisfaction and effective long-term care outcomes.
How much funding has Physera raised?
Physera has raised a total of $10.8M across 2 funding rounds:
Private Equity
$2.8M
Series A
$8M
Private Equity (2017): $2.8M with participation from Expa, Lux Capital, Slow Ventures, and Innovation Endeavors
Series A (2019): $8M, investors not publicly disclosed
Key Investors in Physera
Expa
Expa is a venture capital firm founded by Uber co-founder Garrett Camp, dedicated to helping entrepreneurs create and launch new companies by providing access to capital, office space, and a strong network.
Lux Capital
Lux Capital is a venture capital firm based in New York that invests in early-stage and growth-stage companies at the intersection of science and technology, focusing on areas like AI, robotics, space, and biotechnology.
Innovation Endeavors
Innovation Endeavors is an early-stage venture capital firm that invests in visionary founders and transformational technologies, with a focus on data, computation, and advanced engineering across various industries.
What's next for Physera?
The recent major strategic investment suggests Physera is poised for a significant scaling phase. This capital infusion will likely be directed towards enhancing its technological infrastructure, expanding its service offerings, and broadening its market reach. The company's focus on measurable outcomes and cost-effectiveness positions it favorably in a healthcare landscape increasingly prioritizing value-based care. Future developments may include strategic partnerships and further innovation in virtual chronic condition management.
See full Physera company page